{
  "created_at": "Tue May 25 19:7:8 +0000 2021",
  "id_str": "1397178146223501313",
  "full_text": "The drugmaker Moderna said its Covid-19 vaccine was powerfully effective in 12- to 17-year-olds. It plans to apply for FDA authorization.\nhttps://t.co/impvDDXG0f",
  "display_text_range": [
    0,
    161
  ],
  "entities": {
    "hashtags": [],
    "symbols": [],
    "user_mentions": [],
    "urls": [
      {
        "url": "https://t.co/impvDDXG0f",
        "expanded_url": "https://nyti.ms/3fLoaLw",
        "display_url": "nyti.ms/3fLoaLw",
        "indices": [
          138,
          161
        ]
      }
    ]
  },
  "user": {
    "name": "The New York Times",
    "screen_name": "nytimes",
    "profile_image_url_https": "https://pbs.twimg.com/profile_images/1098244578472280064/gjkVMelR_normal.png"
  },
  "retweet_count": 154,
  "favorite_count": 709,
  "possibly_sensitive": false,
  "original_created_at": "Tue May 25 13:10:03 +0000 2021",
  "localize": [
    {
      "locale": "ja",
      "full_text": "製薬メーカーのModerna社は、Covid-19ワクチンが12歳から17歳の子供たちに強力な効果を発揮したと発表した。今後、FDAの認可を申請する予定です。\nhttps://t.co/impvDDXG0f"
    },
    {
      "locale": "zh",
      "full_text": "制药商Moderna表示，其Covid-19疫苗对12至17岁的儿童具有强大的效力。它计划申请FDA授权。\nhttps://t.co/impvDDXG0f"
    },
    {
      "locale": "zh-Hant",
      "full_text": "製藥商Moderna表示，其Covid-19疫苗對12至17歲的兒童具有強大的效力。它計劃申請FDA授權。\nhttps://t.co/impvDDXG0f"
    }
  ]
}